Skip to main content
. Author manuscript; available in PMC: 2019 Dec 6.
Published in final edited form as: Br J Haematol. 2019 Feb 6;185(6):1021–1042. doi: 10.1111/bjh.15764

Fig 7.

Fig 7.

NK/T cell consortium: Experimental design (NYMC-575)NCT03719105). ANKL, aggressive NK cell leukaemia; enteropathy-associated T cell lymphoma; m-SMILE, modified-steroid (dexamethasone), methotrexate, ifosphamide, etoposide, L-asparaginase; NK, natural killer cell; PTCL, peripheral T cell lymphoma; T, T cell.